GreenLight Biosciences (NASDAQ:GRNA) reported quarterly losses of $(0.27) per share. The company reported $1.73 million in sales this quarter.
Charlie Munger Built A $300M Stock Portfolio For Daily Journal, But Small Publisher Worries It May Not Perform Well Now: ‘It’s Impossible To Ever Replace’
Daily Journal has warned investors of potential lower returns after Charlie Munger's passing, saying it's "impossible to ever replace" him.
